FAKTOR-OPTIONSSCHEIN - ORION B | Market Closed - Börse Stuttgart 15:11:28 2024-06-07 EDT | ||
| 4.57 EUR | -0.65% |
|
| Current month | -13.04% | ||
| 1 month | -28.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ORION OYJ
Latest news about ORION OYJ
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 4.57 | -0.65% |
| 24-06-06 | 4.6 | +4.07% |
| 24-06-05 | 4.42 | -1.12% |
| 24-06-04 | 4.47 | -7.84% |
| 24-06-03 | 4.85 | -8.32% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 03:11 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | ORION OYJ |
| Issuer | Morgan Stanley |
| WKN | MG2WH6 |
| ISIN | DE000MG2WH67 |
| Date issued | 2024-04-24 |
| Strike | 48.55 € |
| Maturity | Unlimited |
| Parity | 2.11 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.77 € |
|---|---|
| Lowest since issue | 4.42 € |
| Spread | 0.02 € |
| Spread % | 0.44% |
Company Profile
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows:
- generic, OTC and biosimilar drugs (43.4%);
- patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments;
- animal health products (8.7%);
- pharmaceutical ingredients and outsourcing services (6.2%).
Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%).
Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Sector
-
Consensus: Orion Oyj
Sell
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
38.84
EUR
Average target price
39
EUR
Spread / Average Target
+0.41%
- Stock Market
- Certificates
- Certificat
